Secondary analysis of German Hodgkin Study Group phase 3 trials in advanced-stage classical Hodgkin lymphoma: at interim PET-2, DS5 was linked to worse PFS vs DS1–3 (HR 3.00) and DS1–4 (HR 2.35) in 639 eBEACOPP patients. The new DS5a was rare (4–6%).
Secondary analysisn = 639
Leiders et al. Validation of the newly introduced Deauville score 5a for patients treated for advanced-stage classic Hodgkin lymphoma